Drug Type Small molecule drug |
Synonyms- |
Target |
Action inhibitors |
Mechanism HIF-2α inhibitors(Endothelial PAS domain-containing protein 1 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Arthritis | Discovery | - | 17 Jan 2023 | |
Endocrinology and Metabolic Disease | Discovery | - | 17 Jan 2023 | |
Enteritis | Discovery | - | 17 Jan 2023 | |
Inflammation | Discovery | - | 17 Jan 2023 | |
Neoplasms | Discovery | - | 17 Jan 2023 | |
Pneumonia | Discovery | - | 17 Jan 2023 | |
Surgical Wound Infection | Discovery | - | 17 Jan 2023 | |
Urogenital Diseases | Discovery | - | 17 Jan 2023 |